
Febumost 40 Tablet
Marketer
Aareen Healthcare Pvt Ltd
Salt Composition
Febuxostat (40mg)
Overview Febumost 40 Tablet
Gout, a condition caused by excessive uric acid crystallizing in joints, resulting in inflammation and pain, is effectively managed with Febumost 40mg tablets. This medication lowers uric acid levels, preventing and treating gout attacks. Febumost 40mg can be administered with or without food; consistent use, as prescribed, is crucial even during symptom-free periods to avoid uric acid buildup and subsequent flare-ups. Dietary modifications (e.g., limiting alcohol and red meat) and increased fluid intake are beneficial. Potential side effects include nausea, liver enzyme abnormalities, skin rashes, and joint discomfort. Initial treatment might trigger a temporary worsening of gout symptoms (intense joint pain, warmth, and redness), but discontinuation is inadvisable. Your physician may prescribe analgesics to alleviate this. Report any signs of liver dysfunction, such as persistent nausea, dark urine, or jaundice, immediately. Prior to commencing treatment, inform your doctor of any pre-existing cardiac issues, stroke history, thyroid disorders, or hepatic or renal impairment. Febumost 40mg is generally contraindicated during pregnancy and lactation; consult your physician. Regular blood tests are necessary to monitor liver function.
Uses of Febumost 40 Tablet
Managing Gout
Major Benefits of Febumost 40 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Febumost 40 Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, but maintaining a consistent daily schedule is recommended.
Common Side effects of Febumost 40 Tablet:
- Nausea
- Skin rash
- Abnormal liver function
- Joint pain
- Rash
How to use Febumost 40 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Febumost 40 Tablet can be consumed with or without food, although consistent timing is recommended.
How Febumost 40 Tablet works:
Gout patients may find relief with Febumost 40 Tablet, a medication that inhibits xanthine oxidase, thus lowering the uric acid levels responsible for gout attacks.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Febumost 40 Tablet concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Febumost 40 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Febumost 40 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Febumost 40 Tablet, which can induce side effects such as dizziness, drowsiness, visual blurring, and numbness or tingling.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Febumost 40 Tablet, as dose modification may be necessary. Physician consultation is advised. Data on Febumost 40 Tablet use in such patients is limited.
LiverCAUTION
Exercise caution when administering Febumost 40 Tablets to individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Data on Febumost 40 Tablet use in such patients is currently limited.
What if you forget to take Febumost 40 Tablet :
Should you forget a Febumost 40 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Febumost 40 Tablet
| Label | Value |
|---|---|
| Type of Compound | Thiozole-based compound |
| Potential for Dependence | None. |
| Medication Classification | Pain relievers |
